STOCK TITAN

AKAMAI TECHNOLOGIES (AKAM) SEC Filings, Nov 2025-Jan 2026

AKAM NASDAQ

Akamai Technologies, Inc. filings document the company's public-company reporting for a Nasdaq-listed common stock issuer focused on cybersecurity, cloud computing, and online application delivery. Recent Form 8-K reports furnish quarterly and annual financial results and segment disclosures for Security, Delivery and other cloud applications, and Cloud Infrastructure Services.

The filing record also includes proxy materials covering board and executive compensation matters, equity incentive plan administration, performance-based bonus measures, and governance disclosures. Regulation FD and other current reports document product announcements such as Akamai Inference Cloud, registered common stock details, and disclosed officer and director open-market stock purchases.

Rhea-AI Summary

Akamai Technologies’ Chief Technology Officer Dr. Robert Blumofe reported a planned stock sale under a Rule 10b5-1 trading plan. On January 22, 2026, he sold 3,500 shares of Akamai common stock at a price of $97 per share under a 10b5-1 plan adopted on March 12, 2025. After this transaction, he beneficially owned 18,074 shares directly, and an additional 90.985 shares indirectly through a 401(k) plan as of January 22, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.77%
Tags
insider
-
Rhea-AI Summary

A shareholder identified as Robert Blumofe has filed a notice of proposed sales of 3,500 shares of Akamai Technologies, Inc. common stock through broker Charles Schwab & Co., Inc., with an indicated aggregate market value of $339,500.00. These shares relate to awards of performance and restricted stock units granted as equity compensation on 02/19/2025 and 02/21/2024, covering 1,887 and 1,613 shares respectively.

The planned sale is listed for an approximate date of 01/22/2026 on the NASDAQ, where Akamai’s common stock is traded. The form also shows that the same shareholder sold 3,500 shares for $301,000.00 on 11/07/2025 and 3,000 shares for $263,051.00 on 11/14/2025. Akamai had 143,865,237 shares of common stock outstanding as referenced in the notice.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
other
-
Rhea-AI Summary

BlackRock, Inc. has disclosed a significant passive ownership stake in Akamai Technologies, Inc. common stock. As of 12/31/2025, BlackRock beneficially owned 10,026,738 Akamai shares, representing 7.0% of the outstanding common stock. It held sole voting power over 9,457,471 shares and sole dispositive power over the full 10,026,738 shares, with no shared voting or dispositive power.

The shares are held across various BlackRock business units on behalf of multiple clients, and no single underlying investor holds more than five percent of Akamai’s common stock. BlackRock certifies that the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Akamai.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.60%
Tags
ownership
Rhea-AI Summary

Akamai Technologies executive Paul C. Joseph, EVP - Global Sales, reported selling 5,000 shares of common stock on January 15, 2026. The sale was executed at a weighted average price of $90.1749 per share, through multiple trades within a price range of $89.80 to $90.62.

According to the filing, the sale was made under a pre-arranged Rule 10b5-1 trading plan that Mr. Joseph adopted on March 17, 2025. After this transaction, he beneficially owned 17,513 shares of Akamai common stock directly, and 116.279 additional shares indirectly through a 401(k) plan as of January 14, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
insider
-
Rhea-AI Summary

Akamai Technologies shareholder Paul C Joseph has filed a notice to sell 10,000 shares of common stock on NASDAQ through Charles Schwab & Co., Inc. The shares have an aggregate market value of $901,749.00 based on the figures in the notice, compared with 143,865,237 shares of Akamai common stock outstanding. The planned sale is scheduled to begin around 01/15/2026.

The notice shows the 10,000 shares were acquired from Akamai Technologies Inc. as equity compensation through performance stock and restricted stock lapses on several dates in February and March 2025, in amounts of 2,594, 2,238, 3,446, and 1,722 shares. Over the past three months, Paul C Joseph previously sold 5,000 Akamai shares on 11/17/2025 for gross proceeds of $438,451.00.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.14%
Tags
other
-
Rhea-AI Summary

Akamai Technologies’ Chief Financial Officer, Mr. McGowan, reported selling 6,560 shares of Akamai common stock on December 15, 2025 at $88.03 per share. The sale was made pursuant to a Rule 10b5-1 Plan that he adopted on September 4, 2025. Following this transaction, he beneficially owns 16,442 shares directly, which includes 9,190 shares for which he has elected to defer receipt under Akamai’s Amended and Restated U.S. Non-Qualified Deferred Compensation Plan, and 66.676 shares held indirectly through a 401(k) plan as of December 12, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.40%
Tags
insider
Rhea-AI Summary

Akamai Technologies reported an insider transaction by its SVP and Chief Accounting Officer, Ms. Howell, in a Form 4. On 12/12/2025, 322 restricted stock units vested and were converted into the same number of Akamai common shares (transaction code M), and 95 shares were disposed of at $85.45 per share (transaction code F).

After these transactions, Ms. Howell directly owns 21,458 Akamai common shares and indirectly holds 109.646 shares through a 401(k) plan as of December 11, 2025. She also continues to hold 967 unvested restricted stock units from a 3,845-unit grant made on September 12, 2023, which vests over three years, with one-third after the first year and the remaining two-thirds in equal quarterly installments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
insider
-
Rhea-AI Summary

Akamai Technologies executive Daniel Joseph reported a planned stock sale under a Rule 10b5-1 trading plan. On 11/17/2025, he sold 5,000 shares of Akamai common stock at a weighted average price of $87.6902, with individual trade prices ranging from $87.33 to $87.95. After this transaction, he beneficially owned 22,349 shares directly and 102.25 shares indirectly through a 401(k) plan, with the 401(k) balance reported as of November 14, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
insider
-
Rhea-AI Summary

Akamai Technologies (AKAM) reported an insider transaction by its Chief Technology Officer. On November 7, 2025, the CTO sold 3,500 shares of common stock at $86 per share, coded “S”. The sale was made pursuant to a Rule 10b5-1 plan adopted on March 12, 2025.

Following the transaction, the reporting person beneficially owned 24,410 shares directly. In addition, 64.184 shares were held indirectly by a 401(k) plan, stated as of November 6, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
insider
Rhea-AI Summary

Akamai Technologies (AKAM) reported higher Q3 results. Revenue was $1,054.6 million, up 5% year over year, and net income rose to $140.2 million from $57.9 million. Diluted EPS was $0.97 versus $0.38. Operating income improved as total costs decreased versus last year’s quarter that included restructuring.

Security led with $568.4 million (up 10%), cloud computing reached $179.7 million (up 8%), while delivery declined to $306.5 million (down 4%). For the nine months, operating cash flow was $1,152.2 million. The company issued $1,725.0 million of 2033 convertible notes, repaid $1,150.0 million of 2025 notes, and ended with total convertible notes principal of $4,140.0 million. Akamai repurchased 10.0 million shares for $800.0 million in the first nine months. Remaining performance obligations were $4.8 billion. Shares outstanding were 143,865,237 as of November 3, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.04%
Tags
quarterly report

FAQ

How many AKAMAI TECHNOLOGIES (AKAM) SEC filings are available on StockTitan?

StockTitan tracks 150 SEC filings for AKAMAI TECHNOLOGIES (AKAM), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AKAMAI TECHNOLOGIES (AKAM)?

The most recent SEC filing for AKAMAI TECHNOLOGIES (AKAM) was filed on January 23, 2026.